These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35879537)

  • 1. Health-Economic Evaluation of the German Osteoporotic Fracture Prevention Program in Rural Areas (OFRA): Mobility and Falls Prevention Classes, Examination of Bone Health, and Consultation on Safety in the Living Environment.
    Konnopka C; Büchele G; Rothenbacher D; Roigk P; Rapp K; König HH
    J Gen Intern Med; 2023 Feb; 38(3):641-647. PubMed ID: 35879537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an osteoporotic fracture prevention program on fracture incidence in routine care: a cluster-randomized trial.
    Rapp K; Lamb SE; Roigk P; Becker C; Konnopka C; König HH; Peter RS; Rothenbacher D; Büchele G
    BMC Med; 2022 Feb; 20(1):49. PubMed ID: 35114993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The osteoporotic fracture prevention program in rural areas (OFRA): a protocol for a cluster-randomized health care fund driven intervention in a routine health care setting.
    Rapp K; Kampe K; Roigk P; Kircheisen H; Becker C; Lindlbauer I; König HH; Rothenbacher D; Büchele G
    BMC Musculoskelet Disord; 2016 Nov; 17(1):458. PubMed ID: 27821102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of an exercise class and use of bone density measurement after advice by the health insurance fund: results from the osteoporotic fracture prevention program in rural areas (OFRA).
    Roigk P; Büchele G; Rehm M; Schulz C; König HH; Becker C; Rapp K
    Aging Clin Exp Res; 2020 Jul; 32(7):1255-1262. PubMed ID: 32146698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partnership for fragility bone fracture care provision and prevention program (P4Bones): study protocol for a secondary fracture prevention pragmatic controlled trial.
    Gaboury I; Corriveau H; Boire G; Cabana F; Beaulieu MC; Dagenais P; Gosselin S; Bogoch E; Rochette M; Filiatrault J; Laforest S; Jean S; Fansi A; Theriault D; Burnand B
    Implement Sci; 2013 Jan; 8():10. PubMed ID: 23343392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of a multifactorial fall prevention program in nursing homes.
    Heinrich S; Rapp K; Stuhldreher N; Rissmann U; Becker C; König HH
    Osteoporos Int; 2013 Apr; 24(4):1215-23. PubMed ID: 22806557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The osteoporotic fracture prevention program in rural areas (OFRA): analysis of 1092 mobility courses in rural areas].
    Roigk P; Büchele G; Kampe K; Rupp K; Rapp K
    Z Gerontol Geriatr; 2019 Feb; 52(1):68-74. PubMed ID: 30073417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of an integrated care programme to avoid fragility fractures of the hip in older adults in 18 Bavarian hospitals - study protocol for the cluster-randomised controlled fracture liaison service FLS-CARE.
    Geiger I; Kammerlander C; Höfer C; Volland R; Trinemeier J; Henschelchen M; Friess T; ; Böcker W; Sundmacher L
    BMC Geriatr; 2021 Jan; 21(1):43. PubMed ID: 33435869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland.
    Lippuner K; Johansson H; Borgström F; Kanis JA; Rizzoli R
    Osteoporos Int; 2012 Nov; 23(11):2579-89. PubMed ID: 22222755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of a fracture liaison service--a real-world evaluation after 6 years of service provision.
    Yong JH; Masucci L; Hoch JS; Sujic R; Beaton D
    Osteoporos Int; 2016 Jan; 27(1):231-40. PubMed ID: 26275439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of the Screening for the Primary Prevention of Fragility Hip Fracture in Spain Using FRAX
    Martin-Sanchez M; Comas M; Posso M; Louro J; Domingo L; Tebé C; Castells X; Espallargues M
    Calcif Tissue Int; 2019 Sep; 105(3):263-270. PubMed ID: 31172231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denosumab for the prevention of osteoporotic fractures in post-menopausal women: a NICE single technology appraisal.
    Scotland G; Waugh N; Royle P; McNamee P; Henderson R; Hollick R
    Pharmacoeconomics; 2011 Nov; 29(11):951-61. PubMed ID: 21854080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women.
    Stevenson M; Davis S; Lloyd-Jones M; Beverley C
    Health Technol Assess; 2007 Feb; 11(4):1-134. PubMed ID: 17280622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fall prevention interventions in primary care to reduce fractures and falls in people aged 70 years and over: the PreFIT three-arm cluster RCT.
    Bruce J; Hossain A; Lall R; Withers EJ; Finnegan S; Underwood M; Ji C; Bojke C; Longo R; Hulme C; Hennings S; Sheridan R; Westacott K; Ralhan S; Martin F; Davison J; Shaw F; Skelton DA; Treml J; Willett K; Lamb SE
    Health Technol Assess; 2021 May; 25(34):1-114. PubMed ID: 34075875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
    Majumdar SR; Lier DA; Hanley DA; Juby AG; Beaupre LA;
    Osteoporos Int; 2017 Jun; 28(6):1965-1977. PubMed ID: 28275838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-economic evaluation of orthogeriatric co-management for patients with pelvic or vertebral fragility fractures.
    Henken E; König HH; Becker C; Büchele G; Friess T; Jaensch A; Rapp K; Rothenbacher D; Konnopka C
    BMC Geriatr; 2024 Aug; 24(1):657. PubMed ID: 39103759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-economic evaluation of collaborative orthogeriatric care for patients with a hip fracture in Germany: a retrospective cohort study using health and long-term care insurance claims data.
    Schulz C; Büchele G; Peter RS; Rothenbacher D; Brettschneider C; Liener UC; Becker C; Rapp K; König HH
    Eur J Health Econ; 2021 Aug; 22(6):873-885. PubMed ID: 33813666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of drugs for osteoporosis treatment in elderly Japanese women at high risk of fragility fractures: comparison of denosumab and weekly alendronate.
    Yoshizawa T; Nishino T; Okubo I; Yamazaki M
    Arch Osteoporos; 2018 Aug; 13(1):94. PubMed ID: 30159632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures.
    Davis S; Martyn-St James M; Sanderson J; Stevens J; Goka E; Rawdin A; Sadler S; Wong R; Campbell F; Stevenson M; Strong M; Selby P; Gittoes N
    Health Technol Assess; 2016 Oct; 20(78):1-406. PubMed ID: 27801641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.